Clinical Reference · Protocol Guide
RENOVÓ
Clinical Protocol
& Selection Guide
A clinical framework for understanding how RENOVÓ biologics are selected, applied, and combined — based on biological indication, tissue environment, and the specific regenerative outcome being addressed.
Clinical CategoriesRegenerative Aesthetics · Pain & Musculoskeletal · Longevity & Healthspan
Document TypePractitioner Reference · Not For Patient Distribution
R
The Clinical Rationale
Product selection within the RENOVÓ platform begins with one question: what does this tissue environment actually require? The answer to that question — and only that answer — determines which biological category or combination is appropriate for this patient, this indication, this tissue.
The three RENOVÓ biological categories each serve a distinct and irreplaceable role. Exosomes carry and deliver biological signals. Wharton's jelly restores the structural environment. Conditioned media provides the immediate soluble factor layer that neither can replicate. The clinical question is always which role — or roles — this tissue environment is asking for.
This document provides the framework for answering that question. Not a fixed protocol to be applied universally, but a biological logic that guides selection toward the most appropriate answer for each individual case.
I
Biological Roles
Understanding What
Each Category Does
I
Exosomes
The Signal Carrier
Membrane-bound vesicles delivering protected biological information — growth factors, signalling proteins, intercellular communication — to recipient cells. Sustained, structured, targeted delivery. The primary driver of cellular response within the RENOVÓ system.
Stands alone — frequently used as sole intervention
When signalling is the primary need and the tissue environment is intact, exosomes alone are often the complete and appropriate answer. EXO selection is driven by source environment and application context.
II
Wharton's Jelly
The Structural Foundation
Extracellular matrix providing the architectural environment within which biological signalling is received and interpreted. Primarily indicated for joints, connective tissue, and musculoskeletal environments where structural degradation is a component of the clinical picture.
Rarely standalone — typically combined with exosomes or conditioned media
Structure without signal has limited effect. Wharton's jelly is most clinically meaningful when paired with a signalling component — exosomes for sustained targeted delivery, conditioned media for immediate broad signal availability, or both.
III
Conditioned Media
The Ambient Signal Layer
Soluble signalling factors released freely in solution — immediate, broad, and transient. Fills the biological communication space that vesicular delivery cannot reach. Not a replacement for exosomes — a complement that expands the signalling environment.
Occasionally standalone — typically used as a complement
Conditioned media is most effective as an adjunct — broadening the immediate signal environment alongside exosome delivery or providing ambient factor exposure within a Wharton's jelly structural matrix.
Selection is always driven by what the tissue environment requires — not by what is most comprehensive, not by budget alone, and not by a fixed protocol. The right answer is the biologically appropriate one for this patient, this tissue, this indication.
II
Clinical Application
Three Clinical Categories.
Distinct Biological Needs.
I
Clinical Category
Regenerative Aesthetics
Skin rejuvenation, hair restoration, facial tissue quality, collagen support, and wound healing environments. The primary biological need is surface-level signalling — connective tissue communication, dermal architecture restoration, and extracellular matrix support at the skin interface. The combinations below describe what practitioners report doing rather than a RENOVÓ recommendation; indication and dosing are the treating clinician's determination.
Primary Protocol
EXO-30Copper Peptide Solution
EXO-30 reconstituted with Copper Peptide Solution for topical delivery. The presentation most frequently ordered for skin and hair applications — surface-oriented Wharton's jelly–derived signalling delivered directly to the tissue interface.
Enhanced Protocol
EXO-50Copper Peptide Solution
EXO-50 reconstituted with Copper Peptide Solution for topical delivery. Higher concentration Wharton's jelly–derived formulation where elevated signalling at the surface environment is clinically appropriate.
Structural Support
EXO-30Copper Peptide SolutionWJ-75
EXO-30 topical delivery combined with WJ-75 — where both surface signalling and extracellular matrix support are indicated. Wharton's jelly provides the architectural foundation alongside the vesicle-mediated signal delivery.
II
Clinical Category
Pain & Musculoskeletal
Tissue environments in which structural degradation, matrix loss, or impaired signalling are components of the clinical picture — spanning sports-related and non-sports musculoskeletal contexts equally. The combinations below describe what practitioners report doing rather than a RENOVÓ recommendation; joint size, severity, and the degree to which structural support or signalling is indicated are determinations for the treating clinician.
Smaller Joints
WJ-95EXO-50
Lyophilised Wharton's jelly for concentrated matrix placement in smaller joint environments, combined with EXO-50 for Wharton's jelly–derived systemic signalling into the restored structural environment.
Structural Joint Signalling
WJ-150EXO-180
Concentrated Wharton's jelly matrix combined with EXO-180's highest-concentration endothelial-derived signalling. Addresses both structural degradation and advanced systemic vascular and tissue repair signalling.
Advanced Structural & Signalling
WJ-300EXO-180
The largest matrix volume paired with the highest concentration endothelial signalling. For expanded joint and tissue environments where maximum structural presence and advanced systemic signalling are both clinically indicated.
Full Biological Environment
WJ-300EXO-90CM-1
The complete biological system — maximum matrix structure, endothelial systemic signalling, and immediate soluble factor availability. Reserved for complex cases where all three biological roles are genuinely indicated.
III
Clinical Category
Longevity & Healthspan
Systemic biological optimisation, cellular age management, immune modulation, neurovascular health, organ-level regenerative support, and whole-body biological environment restoration. The combinations below describe what practitioners report doing rather than a RENOVÓ recommendation; the depth of systemic support required, and whether an ambient soluble factor layer is appropriate alongside the endothelial signalling, are determinations for the treating clinician.
Foundation Protocol
EXO-50or EXO-90
The entry point into systemic longevity support. EXO-50 for connective tissue–oriented systemic signalling or EXO-90 for endothelial-derived vascular, immune, and neurovascular environments. Selection determined by the primary systemic indication.
Advanced Protocol
EXO-180
The highest-content systemic presentation in the platform. EXO-180 is endothelial-derived and used in organ-level, vascular, immune, and neurovascular contexts. Clinical management required.
Expanded Protocol — Full Longevity
EXO-180CM-2
CM-2 adds an immediate, expansive soluble factor layer that an exosome formulation does not provide. EXO-180 and CM-2 are the two highest-content systemic presentations RENOVÓ supplies. Whether to combine them is the treating clinician's decision.
III
Combination Logic
When Products Work
Together
Combinations are not about comprehensiveness. They are about what the tissue environment requires. The following describe the pairings RENOVÓ practitioners report using most often, and the biological logic behind each. They are not RENOVÓ recommendations — indication and dosing are the treating clinician's determination.
Solo Protocol
Exosomes Alone
EXO Series
The most frequent RENOVÓ protocol. When the primary clinical need is signalling — cellular communication, tissue repair coordination, systemic biological support — exosomes alone are often the complete and appropriate answer.
Reported use — where signalling is the primary need and the structural environment is intact
Structural + Signal
Wharton's Jelly & Exosomes
WJ Series+EXO Series
The primary joint and connective tissue combination. Wharton's jelly restores the structural and architectural environment. Exosomes deliver sustained biological signalling into that restored environment.
Reported use — joint, connective tissue, and structural tissue environments
Signal + Ambient
Exosomes & Conditioned Media
EXO Series+CM Series
Sustained vesicle-mediated delivery combined with immediate broad soluble factor availability. The conditioned media provides an ambient signal environment that the exosomes cannot — filling the immediate signalling space while the vesicular delivery provides the longer-duration response.
Reported use — where both immediate and sustained signalling environments are sought
Complete Environment
All Three Categories
WJ+EXO+CM
Reserved for cases where all three biological roles are genuinely indicated — structural matrix restoration, sustained targeted signalling, and immediate ambient factor exposure. This is not the default protocol. It is the appropriate answer for complex tissue environments.
Reported use — complex cases where structural, sustained signal, and immediate signal needs are all present
IV
Quick Reference
Clinical Selection
Framework
Use the following decision framework as a clinical starting point. Each question narrows the selection toward the most biologically appropriate product or combination for the case. It is a reasoning aid rather than a RENOVÓ recommendation — the determination remains the treating clinician's.
Is the primary need signalling or structure?
Signalling only — select from EXO series based on source environment. Surface: EXO-30. Systemic connective tissue: EXO-50. Vascular/systemic: EXO-90 or EXO-180.
Structure is involved — joint, connective tissue, or musculoskeletal environment. Include appropriate WJ formulation. Almost always pair with EXO or conditioned media.
Both — WJ for structural restoration, EXO for sustained signalling. Consider adding conditioned media if immediate ambient signal exposure is also indicated.
What is the application environment?
Surface / topical — EXO-30 is specifically configured for skin and hair environments with collagen peptides. Add WJ-75 where dermal matrix support is indicated.
Internal / systemic — connective tissue — EXO-50 is the foundational Wharton's jelly–derived systemic formulation. Combine with WJ for joint environments.
Internal / systemic — vascular or longevity — EXO-90 for baseline systemic endothelial environments. EXO-180 for advanced clinical systemic contexts.
Is conditioned media indicated?
Yes — as adjunct — when immediate broad soluble factor availability complements the primary intervention. CM-1 for baseline. CM-2 for expanded environments.
Yes — standalone — for specific localised applications where soluble factor exposure alone is the indicated approach. Less common but clinically appropriate in defined contexts.
Not indicated — when the primary intervention adequately addresses the biological need. Conditioned media is a complement, not a requirement.
V
Explaining The Material
Points To Cover.
In Your Own Words.
Set out below is what is substantively true of each RENOVÓ category — what the material is, where it comes from, and what is documented about it. These are points a patient conversation usually needs to cover, not language RENOVÓ supplies to be spoken. The wording, the depth, and what the individual patient actually needs to hear are the practitioner's.
Exosomes
Points to cover
  • Membrane-bound vesicles that cells release to carry signalling proteins and growth factors.
  • RENOVÓ formulations are derived from human umbilical cord tissue.
  • Every lot is screened; particle count and marker profile are documented on the Certificate of Analysis.
  • What is placed at the site is that signalling material.
  • Response is assessed over the course of follow-up.
Wharton's Jelly
Points to cover
  • Joints and connective tissue sit within a structural matrix — the physical environment the tissue occupies.
  • That matrix degrades over time and through injury.
  • Wharton's jelly is the connective tissue matrix of the umbilical cord: hyaluronic acid, collagen, and proteoglycans.
  • It is placed to supply that matrix material to the site.
Conditioned Media
Points to cover
  • The fluid stem cells have been grown in, collected and filtered.
  • It carries the proteins and signalling factors those cells released while they were active.
  • Free in solution rather than packaged inside vesicles — the practical difference from exosomes.
  • The material is present at the site straight away rather than being released over time.
  • Contents are documented per lot.
Combinations
Points to cover
  • More than one component is used when they are different kinds of material, not more of the same.
  • Structural matrix (WJ), signalling material packaged inside vesicles (EXO), signalling material free in solution (CM).
  • Whether to combine, and which, is a clinical judgement made for the individual case.
Clinical Philosophy
The right protocol is not the most comprehensive one.
It is the most biologically appropriate one.
RENOVÓ does not prescribe fixed protocols. It provides the biological framework within which clinical judgment can operate with confidence. Every selection begins with what the tissue environment requires — and ends there too.
This document is provided for practitioner reference and educational purposes only. It does not constitute a medical protocol, prescribe treatment, or replace clinical judgment. RENOVÓ formulations are not intended to diagnose, treat, cure, or prevent any disease or health condition. All clinical decisions remain the sole responsibility of the licensed practitioner. This document is intended for qualified healthcare providers only and is not for patient distribution.
R
RENOVÓ
Clinical Protocol & Selection Guide · Practitioner Reference